O.A.H. Reneerkens

Duinen MV, Reneerkens OA, Lambrecht L, Sambeth A, Rutten BP, Os JV, Blokland A, Prickaerts J (2015). Treatment of Cognitive Impairment in Schizophrenia: Potential Value of Phosphodiesterase Inhibitors in Prefrontal Dysfunction. Curr Pharm Des, 21(26), 3813-28

Reneerkens OA, Sambeth A, Blokland A, Prickaerts J (2013). PDE2 and PDE10, but not PDE5, inhibition affect basic auditory information processing in rats. Behav Brain Res, 250, 251-6.

Reneerkens OA, Sambeth A, Ramaekers JG, Steinbusch HW, Blokland A, Prickaerts J (2013). The effects of the phosphodiesterase type 5 inhibitor vardenafil on cognitive performance in healthy adults: a behavioral-electroencephalography study. J Psychopharmacol, 27(7), 600-8.

Reneerkens OA, Rutten K, Bollen E, Hage T, Blokland A, Steinbusch HW, Prickaerts J (2013). Inhibition of phoshodiesterase type 2 or type 10 reverses object memory deficits induced by scopolamine or MK-801. Behav Brain Res, 236(1), 16-22.

Reneerkens OA, Sambeth A, Van Duinen MA, Blokland A, Steinbusch HW, Prickaerts J (2013). The PDE5 inhibitor vardenafil does not affect auditory sensory gating in rats and humans. Psychopharmacology (Berl), 225(2), 303-12

Akkerman S, Blokland A, Reneerkens O, van Goethem NP, Bollen E, Gijselaers HJ, Lieben CK, Steinbusch HW, Prickaerts J (2012). Object recognition testing: methodological considerations on exploration and discrimination measures. Behav Brain Res, 232(2), 335-47

Reneerkens OA, Rutten K, Akkerman S, Blokland A, Shaffer CL, Menniti FS, Steinbusch HW, Prickaerts J (2012). Phosphodiesterase type 5 (PDE5) inhibition improves object recognition memory: indications for central and peripheral mechanisms. Neurobiol Learn Mem, 97(4), 370-9. doi: 10.1016/j.nlm.2012.02.008

Prickaerts J, van Goethem NP, Chesworth R, Shapiro G, Boess FG, Methfessel C, Reneerkens OA, Flood DG, Hilt D, Gawryl M, Bertrand S, Bertrand D, König G (2012). EVP-6124, a novel and selective α7 nicotinic acetylcholine receptor partial agonist, improves memory performance by potentiating the acetylcholine response of α7 nicotinic acetylcholine receptors. Neuropharmacology, 62(2), 1099-110

de Bruin NM, Prickaerts J, van Loevezijn A, Venhorst J, de Groote L, Houba P, Reneerkens O, Akkerman S, Kruse CG. Two novel 5-HT6 receptor antagonists ameliorate scopolamine-induced memory deficits in the object recognition and object location tasks in Wistar rats. Neurobiol Learn Mem., 96(2), 392-402.

Reneerkens OA, Rutten K, Steinbusch HW, Blokland A, Prickaerts J (2009). Selective phosphodiesterase inhibitors: a promising target for cognition enhancement. Psychopharmacology (Berl), 202(1-3), 419-43

Rutten K, Reneerkens OA, Hamers H, Sik A, McGregor IS, Prickaerts J, Blokland A. (2008). Automated scoring of novel object recognition in rats. J Neurosci Methods, 171(1), 72-7